These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 11735247)
1. Transcriptional regulation of IGF-I receptor gene expression by the PAX3-FKHR oncoprotein. Ayalon D; Glaser T; Werner H Growth Horm IGF Res; 2001 Oct; 11(5):289-97. PubMed ID: 11735247 [TBL] [Abstract][Full Text] [Related]
2. The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator. Sublett JE; Jeon IS; Shapiro DN Oncogene; 1995 Aug; 11(3):545-52. PubMed ID: 7630639 [TBL] [Abstract][Full Text] [Related]
3. Wild type PAX3 protein and the PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domains. Bennicelli JL; Fredericks WJ; Wilson RB; Rauscher FJ; Barr FG Oncogene; 1995 Jul; 11(1):119-30. PubMed ID: 7624119 [TBL] [Abstract][Full Text] [Related]
4. The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3. Fredericks WJ; Galili N; Mukhopadhyay S; Rovera G; Bennicelli J; Barr FG; Rauscher FJ Mol Cell Biol; 1995 Mar; 15(3):1522-35. PubMed ID: 7862145 [TBL] [Abstract][Full Text] [Related]
5. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma. Barr FG Oncogene; 2001 Sep; 20(40):5736-46. PubMed ID: 11607823 [TBL] [Abstract][Full Text] [Related]
6. Mechanism for transcriptional gain of function resulting from chromosomal translocation in alveolar rhabdomyosarcoma. Bennicelli JL; Edwards RH; Barr FG Proc Natl Acad Sci U S A; 1996 May; 93(11):5455-9. PubMed ID: 8643596 [TBL] [Abstract][Full Text] [Related]
7. Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma. Davis RJ; Barr FG Proc Natl Acad Sci U S A; 1997 Jul; 94(15):8047-51. PubMed ID: 9223312 [TBL] [Abstract][Full Text] [Related]
8. PAX3/forkhead homolog in rhabdomyosarcoma oncoprotein activates glucose transporter 4 gene expression in vivo and in vitro. Armoni M; Quon MJ; Maor G; Avigad S; Shapiro DN; Harel C; Esposito D; Goshen Y; Yaniv I; Karnieli E J Clin Endocrinol Metab; 2002 Nov; 87(11):5312-24. PubMed ID: 12414908 [TBL] [Abstract][Full Text] [Related]
9. Detection of PAX3-FKHR and PAX7-FKHR fusion transcripts in rhabdomyosarcoma by reverse transcriptase-polymerase chain reaction using paraffin-embedded tissue. Chen BF; Chen ML; Liang DC; Huang YW; Liu HC; Chen SH Zhonghua Yi Xue Za Zhi (Taipei); 1999 Feb; 62(2):86-91. PubMed ID: 10063718 [TBL] [Abstract][Full Text] [Related]
10. An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogene. Fredericks WJ; Ayyanathan K; Herlyn M; Friedman JR; Rauscher FJ Mol Cell Biol; 2000 Jul; 20(14):5019-31. PubMed ID: 10866659 [TBL] [Abstract][Full Text] [Related]
11. Normal and rearranged PAX3 expression in human rhabdomyosarcoma. Frascella E; Toffolatti L; Rosolen A Cancer Genet Cytogenet; 1998 Apr; 102(2):104-9. PubMed ID: 9546061 [TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor II and PAX3-FKHR cooperate in the oncogenesis of rhabdomyosarcoma. Wang W; Kumar P; Wang W; Epstein J; Helman L; Moore JV; Kumar S Cancer Res; 1998 Oct; 58(19):4426-33. PubMed ID: 9766674 [TBL] [Abstract][Full Text] [Related]
13. Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome? Anderson J; Gordon T; McManus A; Mapp T; Gould S; Kelsey A; McDowell H; Pinkerton R; Shipley J; Pritchard-Jones K; Br J Cancer; 2001 Sep; 85(6):831-5. PubMed ID: 11556833 [TBL] [Abstract][Full Text] [Related]
14. The Pax3-FKHR oncoprotein is unresponsive to the Pax3-associated repressor hDaxx. Hollenbach AD; Sublett JE; McPherson CJ; Grosveld G EMBO J; 1999 Jul; 18(13):3702-11. PubMed ID: 10393185 [TBL] [Abstract][Full Text] [Related]
15. PAX3-FKHR induces morphological change and enhances cellular proliferation and invasion in rhabdomyosarcoma. Anderson J; Ramsay A; Gould S; Pritchard-Jones K Am J Pathol; 2001 Sep; 159(3):1089-96. PubMed ID: 11549601 [TBL] [Abstract][Full Text] [Related]
16. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. Sorensen PH; Lynch JC; Qualman SJ; Tirabosco R; Lim JF; Maurer HM; Bridge JA; Crist WM; Triche TJ; Barr FG J Clin Oncol; 2002 Jun; 20(11):2672-9. PubMed ID: 12039929 [TBL] [Abstract][Full Text] [Related]
17. The role of chimeric paired box transcription factors in the pathogenesis of pediatric rhabdomysarcoma. Barr FG Cancer Res; 1999 Apr; 59(7 Suppl):1711s-1715s. PubMed ID: 10197585 [TBL] [Abstract][Full Text] [Related]
18. Hormone-dependent tumor regression in vivo by an inducible transcriptional repressor directed at the PAX3-FKHR oncogene. Ayyanathan K; Fredericks WJ; Berking C; Herlyn M; Balakrishnan C; Gunther E; Rauscher FJ Cancer Res; 2000 Oct; 60(20):5803-14. PubMed ID: 11059777 [TBL] [Abstract][Full Text] [Related]
19. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Galili N; Davis RJ; Fredericks WJ; Mukhopadhyay S; Rauscher FJ; Emanuel BS; Rovera G; Barr FG Nat Genet; 1993 Nov; 5(3):230-5. PubMed ID: 8275086 [TBL] [Abstract][Full Text] [Related]
20. Cell-type-specific regulation of distinct sets of gene targets by Pax3 and Pax3/FKHR. Begum S; Emami N; Cheung A; Wilkins O; Der S; Hamel PA Oncogene; 2005 Mar; 24(11):1860-72. PubMed ID: 15688035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]